Blood urea nitrogen - independent marker of mortality in sepsis

Martin Harazim1,2,3, Kaiquan Tan4, Marek Nalos1,4,5

  • 1ICU, Department of Internal Medicine I, Faculty of Medicine, Charles University and University Hospital Pilsen, Czech Republic.

Insights

High admission Blood Urea Nitrogen (BUN) levels in sepsis patients predict a greater risk of 28-day mortality. This easily measured biomarker can aid in predicting outcomes for critically ill sepsis patients.

Area of Science:

  • Critical Care Medicine
  • Nephrology
  • Epidemiology

Background:

  • Sepsis is a life-threatening organ dysfunction caused by a dysregulated host response to infection.
  • Early identification of patients at high risk of mortality is crucial for timely intervention.
  • Blood Urea Nitrogen (BUN) is a commonly measured laboratory parameter in critically ill patients.

Purpose of the Study:

  • To investigate the association between admission Blood Urea Nitrogen (BUN) levels and 28-day mortality in patients with sepsis.
  • To determine if BUN is an independent predictor of mortality in this population.

Main Methods:

  • Retrospective analysis of 9126 sepsis patients from two cohorts (Czech Republic and United States) between January 2014 and December 2018.
  • Kaplan-Meier survival analysis and Cox regression models were employed.
  • An optimal BUN cut-off for predicting 28-day mortality was determined using the Youden Index.

Main Results:

  • Admission BUN levels were categorized into 10-20, 20-40, and >40 mg/dL.
  • Patients with the highest BUN levels (>40 mg/dL) had a significantly increased hazard ratio (HR) for 28-day mortality (2.764) compared to the lowest levels (10-20 mg/dL).
  • An optimal BUN cut-off of 23 mg/dL was identified for predicting 28-day mortality. This association remained significant after adjusting for confounders like APACHE IV, SAPS2, and eGFR.

Conclusions:

  • Admission Blood Urea Nitrogen (BUN) is a valuable and readily available independent predictor of 28-day mortality in critically ill sepsis patients.
  • Elevated BUN levels at ICU admission are associated with poorer clinical outcomes in sepsis.
  • This finding supports the routine use of BUN for risk stratification in sepsis management.
Abstract

Related Concept Videos

Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
83
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
243
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
381
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
69
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
128
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
106